Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Separation Systems for Commercial Biotechnology Market, 2025 - Analysis By Methods, By Application, And Segment Forecasts - Research and Markets

Research and Markets
Posted on: 06 Nov 17

The "Separation Systems for Commercial Biotechnology Market Analysis By Methods, By Application, And Segment Forecasts, 2014 - 2025" report has been added to Research and Markets' offering.

The global separation system for commercial biotechnology market is expected to reach USD 39.47 billion by 2025

Intensive research in the field of biotechnology to develop advanced products is expected to boost growth in the coming years. Moreover, contributions of leading industrial entities in this sector for accelerating commercial production is anticipated to drive the market.

Government bodies are providing funds to small & medium enterprises for the development of novel technologies. This is expected to enhance the efficiency of large-scale upstream bioprocessing systems used for separation & purification of biomolecules. Such instruments are extensively used for production of food & cosmetics, agriculture, plastics, and chemicals.

Moreover, the popularity of technologically advanced single-use bioprocessing systems in various industries, such as agro-processing, chemical & plastics is contributing toward the growth of the upstream processing sector. Rising cases of chronic & severe metabolic & genetic disorders are ultimately increasing the demand of potential therapeutics. Rising demand for biopharmaceuticals is likely to result in lucrative growth.

Furthermore, changing healthcare reforms and public -private collaborations among industrial players, government, and research institutions are expected to improve the technological aspects of separation methods. Thus, in turn, is anticipated to significantly render the growth of commercial separation market over the forecast period.

Key Topics Covered:

Chapter 1 Research Methodology

Chapter 2 Executive Summary

Chapter 3 Separation Systems for Commercial Biotechnology, Trends & Scope

Chapter 4 Separation Systems for Commercial Biotechnology: Methods Estimates & Trend Analysis

Chapter 5 Separation Systems for Commercial Biotechnology: Application Estimates & Trend Analysis

Chapter 6 Separation Systems for Commercial Biotechnology: Regional Estimates & Trend Analysis by Methods & Application

Chapter 7 Competitive Landscape

  • Perkin Elmer, Inc.
  • Sartorius AG.
  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • Danaher
  • Becton, Dickinson and Company (BD)
  • Shimadzu Corporation
  • bioMrieux SA
  • Agilent Technologies
  • Bio-Rad Laboratories, Inc.
  • Hitachi Koki Co., Ltd.
  • QIAGEN
  • General Electric Company (GE healthcare)
  • WATERS
  • Miltenyi Biotec Inc.

For more information about this report visit https://www.researchandmarkets.com/research/rdbmlk/separation

View source version on businesswire.com: http://www.businesswire.com/news/home/20171106005589/en/

Business Wire
www.businesswire.com

Last updated on: 06/11/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.